| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |